|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 12, 2016 ) A type of biological therapy, Monoclonal Antibodies is produced by a single clone of cells consisting of identical antibody molecules. They have proven to be useful for various applications (treatment of cancer, multiple sclerosis, and viral infections, among others) which accelerated the demand for the product in Global Monoclonal Antibodies market and is anticipated to gain momentum during the forecast period. At present, there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases, and many of these products have also been approved in the global markets.
View report page at “http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/”
At the current approval rate of four new products releasing every year, approximately 70 monoclonal antibody products are expected to be present on the market by 2020.
Get sample brochure at “http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/request-sample”
Global Monoclonal Antibodies market is driven by boost in R & D investment in genomics and adoption of cutting-edge technology. The development of new molecules is expected to play a prominent role due to the cost effectiveness of technology during the forecast period. However, huge cost and long-time associated with the identification and development of potential molecules is a major factor impeding the growth of the market.
Enquire more before buying at “http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/inquire”
Segmentation
By source
• Murine
• Chimeric
• Humanized
• Human
By Indication
• Cancer
• Blood Cancer
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Pancreatic Cancer
• Others
• Auto immune diseases
• Infectious diseases
• Cardiovascular diseases
• CNS disorders
• Others
By End User
• Hospitals/Clinics
• Research Institute
• Diagnostic Laboratories
By application
• Medical
• Experimental
• Western Blot
• ELISA
• Radioimmune Assays
• Immunofluorescence
• Others
• Y-o-Y Growth Rate, by Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
By Geography
• North America Monoclonal Antibodies Market
• Europe Monoclonal Antibodies Market
• Asia-Pacific Monoclonal Antibodies Market
• Latin America Monoclonal Antibodies Market
• Middle-East & Africa Monoclonal Antibodies Market
some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China).
Buy now “https://www.marketdataforecast.com/cart/buy-now/global-monoclonal-antibodies-market-1184”
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
